Vical Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VICL Nasdaq 2836 http://www.vical.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vical Incorporated

What Investors Should Know About Vical Incorporated’s (NASDAQ:VICL) Financial Strength - Dec 12th, 2018 10:22 am
New Research: Key Drivers of Growth for Interface, USA Truck, Weingarten Realty Investors, Unum Group, Trivago N.V. ADS, and Vical — Factors of Influence, Major Initiatives and Sustained Production - Nov 1st, 2018 6:15 am
Vical (VICL) Reports Q3 Loss, Misses Revenue Estimates - Oct 29th, 2018 5:50 am
Vical: 3Q Earnings Snapshot - Oct 29th, 2018 4:43 am
Vical (VICL) Q3 Earnings Preview: What to Know Ahead of the Release - Oct 15th, 2018 8:30 am
Who Are The Major Shareholders In Vical Incorporated (NASDAQ:VICL)? - Oct 9th, 2018 12:03 pm
Vical (VICL) Reports Q2 Loss, Tops Revenue Estimates - Aug 7th, 2018 5:55 am
When Will Vical Incorporated (NASDAQ:VICL) Become Profitable? - Jun 27th, 2018 9:18 am
Does Vical Incorporated’s (NASDAQ:VICL) Past Performance Indicate A Weaker Future? - May 15th, 2018 6:35 pm
Edited Transcript of VICL earnings conference call or presentation 3-May-18 4:00pm GMT - May 8th, 2018 5:43 pm